IRCT201008094541N1已完成3 期
The assessment of effect of Tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia on patients treated with standard medication
Guilan University of Medical Sciences0 个研究点目标入组 132 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 132
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 years 至 80 years（—）
- 性别
- Male
入选标准
- •patients with score > 8 and without any indications for prostatic surgery such as recurrent retention, persistent gross hematuria, permanent urinary infections associated with BPH, renal function failure and hydronephrosis, bladder stone due to BPH, under previous standard medical treatment with prazocine (max doze 10mg) daily with or without Finastride (5 mg, daily, for 3 months). Response to medication should be in plateau level
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
The role of tadalafil for lower urinary tract symptoms after brachytherapyProstatic cancerJPRN-UMIN000015767Department of Urology, Shinshu University Hospital200
尚未招募
不适用
Effect of tadarafil on lower urinary tract symptoms in patients treated with low dose rate brachytherapy for prostate cancerProstate cancerJPRN-UMIN000047981ara Medical University220
招募中
不适用
Tadalafil for painful bladderCTRI/2018/03/012720Dr Gajanan Bhat
已完成
1 期
Effects of Single Dose Tadalafil on Urethral and Anal Closure FunctionUrinary Incontinence,StressFecal IncontinenceNCT05095077University Hospital Bispebjerg and Frederiksberg24
已完成
不适用
The effect of tadalafil compared to tamsulosin and placebo on the symptoms of double-J stent insertion in men with ureter stonesCondition 1: Lower urinary tract symptoms. Condition 2: Pain in the flank and suprapubic areas. Condition 3: Sexual function.Calculus of lower urinary tractOther and unspecified abdominal painUnspecified sexual dysfunction, not caused by organic disorder or diseaseIRCT201702261853N13rology Research Centre, Guilan University of Medical Sciences120